|
Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and Scottish Equity Partners. In June 2014, it acquired Cappella Peel Away Inc.
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
Stock A |
1 |
26,824,657 |
26,805,915 |
99.9% |
18,742 |
0.1% |
99.9% |
|
|
|
Sector Other Medical Equipment, Supplies & Distribution
|